Tuesday, December 27, 2016

The dawn of mRNA-based therapeutics for brain diseases

The progressive dementia suffered by patients with Alzheimer’s disease (AD) affects millions of people globally each year and puts considerable strain on healthcare services. The mechanisms behind AD are not yet clear, and there are no effective therapies available to fully tackle the disease.

from Dementia Big http://ift.tt/2hkbsDb via alcoholic dementia


http://ift.tt/2izvVZS

No comments:

Post a Comment